绝经后骨质疏松症中简短、低冲击、高强度成骨负荷干预:一项准实验病例系列研究
这项准实验病例系列研究纳入147名围绝经期或绝经后骨质疏松女性,分为接受Osteostrong®干预的A组75例(G1不用、G2用抗骨吸收药)和未接受该干预的B组72例(G3不用、G4用抗骨吸收药),评估12个月腰椎和髋部骨密度与骨小梁评分变化。G2腰椎骨密度平均配对变化0.029 g/cm2(Bonferroni校正后p<0.001),G4为0.025 g/cm2(校正后p=0.05),G2左全髋骨密度为0.028 g/cm2(校正后p=0.05);其余指标经Bonferroni校正后未保留显著性。作者认为该干预在12个月内显示腰椎骨密度轻度改善,部分亚组效应在校正后不再显著,需谨慎解读并进一步开展随机试验。
要点
- Osteostrong®为每周1次、每次10分钟、低冲击高强度的成骨负荷训练,使用4台设备。
- G2(Osteostrong®联合抗骨吸收药)腰椎骨密度平均配对变化0.029 g/cm2,Bonferroni校正后p<0.001。
- G4(仅抗骨吸收药)腰椎骨密度平均配对变化0.025 g/cm2,校正后p=0.05;G2左全髋为0.028 g/cm2,校正后p=0.05。
核心结论
- Osteostrong®干预在12个月内显示腰椎骨密度轻度改善;部分亚组效应显著,但经Bonferroni校正后不再显著,需谨慎解读并进一步开展随机试验。
研究设计与样本
- 准实验病例系列研究,147名围绝经期或绝经后骨质疏松女性知情同意后分为两组:A组75例接受Osteostrong®(G1不用、G2用抗骨吸收药),B组72例不接受Osteostrong®(G3不用、G4用抗骨吸收药)。
- 在入组时和12个月后评估腰椎和髋部骨密度和/或骨小梁评分变化,采用Bonferroni校正的非参数配对检验分析各亚组内配对均值差异。
主要发现
- 经Bonferroni校正后,G2腰椎骨密度平均配对变化0.029 g/cm2(校正后p<0.001),G4为0.025 g/cm2(校正后p=0.05),G2左全髋骨密度为0.028 g/cm2(校正后p=0.05)。
- 股骨颈骨密度、全髋骨密度和骨小梁评分的其他组内变化经Bonferroni校正后未保留显著性。
临床怎么用
- 作者认为Osteostrong®干预在12个月内显示腰椎骨密度轻度改善,部分亚组效应显著但Bonferroni校正后不再显著,需谨慎解读并进一步开展随机试验。
局限性
- 原文结论自述部分亚组效应经Bonferroni校正后不再显著,需谨慎解读,并需进一步开展随机试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoporosis is characterized by reduced bone mineral density (BMD) and disrupted microarchitecture estimated by trabecular bone score (TBS). Osteostrong® is a bone-strengthening system implementing 4 devices and incorporating brief (10-minute), weekly, low-impact, high-intensity osteogenic loading exercises. The aim of this study was to assess changes in BMD and TBS in the lumbar spine and/or hip over 12 months in peri-/post menopausal women with Osteoporosis following Osteostrong® intervention and to compare these outcomes with women who did not receive such intervention. METHODS AND SUBJECTS: A quasi-experimental case-series study in which 147 participants were separated into 2 groups, following informed consent: 75 in group A receiving Osteostrong® (subgroup G1 without and G2 with antiresorptive medication); and 72 in group B without Osteostrong® (subgroup G3 without and G4 with antiresorptive medication). Changes in lumbar spine and hip BMD and/or TBS were assessed at inclusion and 12 months later. Bonferroni-adjusted non-parametric paired tests examined for significant paired mean differences within each subgroup. RESULTS: After Bonferroni adjustment, significant increases were observed in lumbar spine BMD in G2 (mean paired change: 0.029 g/cm2; Bonferroni-adjusted p < 0.001), and G4 (mean paired change: 0.025 g/cm2; Bonferroni-adjusted p = 0.05) as well as BMD-total hip left in G2 (mean paired change: 0.028 g/cm2; Bonferroni-adjusted p = 0.05). Other within-group changes in femoral neck BMD, total hip BMD, and TBS did not retain significance following Bonferroni correction. CONCLUSION: The Osteostrong® intervention showed modest lumbar spine BMD improvements over 12 months; some subgroup effects were significant but not when Bonferroni-adjusted, warranting cautious interpretation and further randomized trials.
引用
- Papadopoulou-Marketou N, Papageorgiou A, Marketos N, et al. Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal Osteoporosis: A Quasi-experimental Case-series Study. J Clin Endocrinol Metab. 2025. PMID: 39918073. doi:10.1210/clinem/dgaf077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。